Literature DB >> 29134403

Femtosecond lenticule extraction performed on a wrong meridian and effectively reversed by excimer laser ablation.

Alper Agca1, Yusuf Yildirim1, Burçin Kepez Yildiz2, Dilek Yasa1, Ali Demircan1, Ahmet Demirok1.   

Abstract

Year:  2017        PMID： 29134403     DOI： 10.1007/s10103-017-2380-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN： 0268-8921            Impact factor:   3.161


× No keyword cloud information.
  6 in total

1.  Flap relift for retreatment after femtosecond laser-assisted LASIK.

Authors:  Marcony R Santhiago; David Smadja; Kelly Zaleski; Edgar M Espana; Brian K Armstrong; Steven E Wilson
Journal:  J Refract Surg       Date:  2012-07       Impact factor: 3.573

2.  Results of small incision lenticule extraction: All-in-one femtosecond laser refractive surgery.

Authors:  Rupal Shah; Samir Shah; Sayantan Sengupta
Journal:  J Cataract Refract Surg       Date:  2011-01       Impact factor: 3.351

3.  Femtosecond (FS) laser vision correction procedure for moderate to high myopia: a prospective study of ReLEx(®) flex and comparison with a retrospective study of FS-laser in situ keratomileusis.

Authors:  Anders Vestergaard; Anders Ivarsen; Sven Asp; Jesper Ø Hjortdal
Journal:  Acta Ophthalmol       Date:  2012-04-18       Impact factor: 3.761

Review 4.  Retreatment of LASIK.

Authors:  Namrata Sharma; Ramamurthy Balasubramanya; Rajesh Sinha; Jeewan S Titiyal; Rasik B Vajpayee
Journal:  J Refract Surg       Date:  2006-04       Impact factor: 3.573

5.  Enhancement of femtosecond lenticule extraction for visual symptomatic eye after myopia correction.

Authors:  Jing Zhao; Peijun Yao; Zhi Chen; Meiyan Li; Yang Shen; Huamao Miao; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2014-05-18       Impact factor: 2.209

6.  Induced Higher-order aberrations after Laser In Situ Keratomileusis (LASIK) Performed with Wavefront-Guided IntraLase Femtosecond Laser in moderate to high Astigmatism.

Authors:  Ferial M Al-Zeraid; Uchechukwu L Osuagwu
Journal:  BMC Ophthalmol       Date:  2016-03-22       Impact factor: 2.209
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.